Clinical trial
PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e…
NCT00371761 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00371761 |
|---|---|
| Title | PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278) |
| Official title | An Open-Label, Randomized, Comparative Study With PegIntron vs. Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic (CHB) |
| Intervention type | Biological, Drug |
| Interventions | Pegylated interferon alfa-2b (PegIntron), Adefovir dipivoxil (adefovir) |
| Enrollment | 25 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Sep 4, 2006 |
| Last update posted | Apr 6, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: